Diagnostic value of circulating genetically abnormal cells to support computed tomography for benign and malignant pulmonary nodules

The accuracy of CT and tumour markers in screening lung cancer needs to be improved. Computeraided diagnosis has been reported to effectively improve the diagnostic accuracy of imaging data, and recent studies have shown that circulating genetically abnormal cell (CAC) has the potential to become a novel marker of lung cancer.